SOBI-003

DB15451Investigational

SOBI-003 is a chemically modified variant of a recombinant human sulfamidase. It is under investigation in clinical trial NCT03811028 (A Study to Assess the Safety, Tolerability, and Efficacy of Long-term...

Mechanism: Pharmacologically active on N-sulphoglucosamine sulphohydrolase
Curator reviewed
Also known as: Chemically modified recombinant sulfamidase
Code names: SOBI-003

Resolves to

Compound

UNIIZS87P77DQC

Targets

P51688SGSH

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with SOBI-003, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account